Learn More
Description
The S2-647 monoclonal antibody recognizes the Von Hippel-Lindau (VHL) protein. The VHL protein is expressed within the cytosol and nuclei of cells from a variety of tissues. It serves as a tumor suppressor and transcriptional repressor that is highly conserved from Drosophila to mammalian species. VHL binds to Elongin B and C subunits and other proteins as part of a E3 ubiquitin ligase complex that targets a variety of proteins, including HIF-1 alpha and Beta-2 adrenergic receptors, for proteasomal degradation. Aberrant VHL expression is associated with a number of diseases including Von Hippel-Lindau disease, a familial cancer syndrome, that predisposes individuals to hemangioblastomas of the central nervous system and retina, pheochromocytoma and renal cell carcinoma. Three distinct VHL isoforms ranging in molecular weight from approximately 19-30 kDa have been described.
Specifications
Specifications
| Antigen | VHL |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | S2-647 |
| Conjugate | Alexa Fluor 647 |
| Description | VHL1; pVHL; Elongin binding protein; Protein G7; HRCA1; RCA1 |
| Host Species | Mouse |
| Immunogen | Human VHL Recombinant Protein |
| Purification Method | Affinity Purified |
| Quantity | 50 Tests |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.